Trachoma in Yunnan province of southwestern China: findings from trachoma rapid assessment
Background To understand the situation of active trachoma among children aged 6 to 8 years old and scarring trachoma among those aged 15 and over in Yunnan Province, South-western China.
Min Wu +4 more
doaj +1 more source
Trachoma rapid assessments in Unity and Northern Bahr-el-Ghazal States, Southern Sudan. [PDF]
BACKGROUND: Trachoma is thought to be endemic over large parts of Southern Sudan, but empirical evidence is limited. While some areas east of the Nile have been identified as highly endemic, few trachoma surveys have been conducted in the remainder of ...
Emily Robinson +7 more
doaj +1 more source
Stopping azithromycin mass drug administration for trachoma: A systematic review.
The World Health Organization (WHO) recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1-9 years.
Hamidah Mahmud +8 more
doaj +1 more source
Blinding trachoma among refugees: complicating social disaster
Objective:: To determine the prevalence of blinding trachoma among refugees in South Western Ethiopia. Methods:: A cross-sectional outreach clinic based descriptive study was conducted on 1 054 refugees in Southwest Ethiopia.
Yeshigeta Gelaw, Aemero Abateneh
doaj +1 more source
The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up. [PDF]
BACKGROUND: The natural history of ocular Chlamydia trachomatis infections in endemic communities has not been well characterised and is an important determinant of the effectiveness of different mass treatment strategies to prevent blindness due to ...
Nicholas C Grassly +14 more
core +1 more source
Incremental cost of conducting population-based prevalence surveys for a neglected tropical disease: the example of trachoma in 8 national programs. [PDF]
BACKGROUND: Trachoma prevalence surveys provide the evidence base for district and community-wide implementation of the SAFE strategy, and are used to evaluate the impact of trachoma control interventions.
Cromwell, Elizabeth A +25 more
core +2 more sources
Trachoma recrudescence is a serious concern for trachoma control programs. Programs define recrudescence as the return of trachomatous inflammation-follicular (TF) prevalence above elimination threshold (≥5%) on district-level trachoma surveillance ...
Eshetu Sata +15 more
doaj +1 more source
Trachoma elimination in Latin America: prioritization of municipalities for surveillance activities
Objective. To identify and prioritize municipalities in 22 countries of Latin America for trachoma surveillance activities, to measure the absence or prevalence of trachoma, and to support validation and trachoma elimination efforts in the Region of the ...
Martha Idalí Saboyá-Díaz +5 more
doaj +1 more source
THE TREATMENT OF TRACHOMA AND TRACHOMA SEQUELÆ. [PDF]
Trachoma cases come to us for treatment not only in all stages and states of active disease—such as acute, sub-acute and chronic—but also after the affection has worn itself out; been consumed by its own fire, so to speak, and we have to do only with its effects; and every phase of the morbid process, every attendant complication and, lastly, every ...
openaire +1 more source
Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines. [PDF]
The immunological basis of scarring trachoma is not well understood. It is unclear whether it is driven primarily through cell-mediated adaptive or epithelial-cell-derived innate responses.
Victor Hu +19 more
core +1 more source

